360 related articles for article (PubMed ID: 30470622)
1. Mitchell-Hoole-Kanatas (MHK) questionnaire: the first to measure patient-reported outcomes relating to problems with intimacy after diagnosis and treatment of head and neck cancer.
Hoole J; Mitchell DA; Smith AB; Kanatas A
Br J Oral Maxillofac Surg; 2018 Dec; 56(10):910-917. PubMed ID: 30470622
[TBL] [Abstract][Full Text] [Related]
2. Validated questionnaires on intimacy in patients who have had cancer.
Hoole J; Kanatas A; Calvert A; Rogers SN; Smith AB; Mitchell DA
Br J Oral Maxillofac Surg; 2015 Sep; 53(7):584-93. PubMed ID: 26037739
[TBL] [Abstract][Full Text] [Related]
3. Issues of intimacy and sexual dysfunction following major head and neck cancer treatment.
Low C; Fullarton M; Parkinson E; O'Brien K; Jackson SR; Lowe D; Rogers SN
Oral Oncol; 2009 Oct; 45(10):898-903. PubMed ID: 19457705
[TBL] [Abstract][Full Text] [Related]
4. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
5. Quality of life in head and neck cancer survivors: a cross-sectional survey.
Chaukar DA; Walvekar RR; Das AK; Deshpande MS; Pai PS; Chaturvedi P; Kakade A; D'Cruz AK
Am J Otolaryngol; 2009; 30(3):176-80. PubMed ID: 19410123
[TBL] [Abstract][Full Text] [Related]
6. Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35).
Sherman AC; Simonton S; Adams DC; Vural E; Owens B; Hanna E
Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):459-67. PubMed ID: 10772298
[TBL] [Abstract][Full Text] [Related]
7. Development of a Patient-Centered Functional Outcomes Questionnaire in Head and Neck Cancer.
Mendez A; Seikaly H; Eurich D; Dzioba A; Aalto D; Osswald M; Harris JR; O'Connell DA; Lazarus C; Urken M; Likhterov I; Chai RL; Rauscher E; Buchbinder D; Okay D; Happonen RP; Kinnunen I; Irjala H; Soukka T; Laine J;
JAMA Otolaryngol Head Neck Surg; 2020 May; 146(5):437-443. PubMed ID: 32271362
[TBL] [Abstract][Full Text] [Related]
8. Development of a head and neck companion module for the quality of life-radiation therapy instrument (QOL-RTI).
Trotti A; Johnson DJ; Gwede C; Casey L; Sauder B; Cantor A; Pearlman J
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):257-61. PubMed ID: 9788402
[TBL] [Abstract][Full Text] [Related]
9. PROMIS evaluation for head and neck cancer patients: a comprehensive quality-of-life outcomes assessment tool.
Stachler RJ; Schultz LR; Nerenz D; Yaremchuk KL
Laryngoscope; 2014 Jun; 124(6):1368-76. PubMed ID: 24719292
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer.
Yang CJ; Roh JL; Kim MJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Qual Life Res; 2016 Jan; 25(1):165-74. PubMed ID: 26156405
[TBL] [Abstract][Full Text] [Related]
11. The Head and Neck Cancer Patient Concern Inventory
Aguilar ML; Sandow P; Werning JW; Brenneman L; Psoter WJ
J Prosthodont; 2017 Apr; 26(3):186-195. PubMed ID: 28220985
[TBL] [Abstract][Full Text] [Related]
12. Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer: Results of a prospective study.
Tribius S; Raguse M; Voigt C; Münscher A; Gröbe A; Petersen C; Krüll A; Bergelt C; Singer S
Strahlenther Onkol; 2015 Jun; 191(6):501-10. PubMed ID: 25747264
[TBL] [Abstract][Full Text] [Related]
13. Population-based reference values for the European Organization for Research and Treatment of Cancer Head and Neck module.
Hammerlid E; Adnan A; Silander E
Head Neck; 2017 Oct; 39(10):2036-2047. PubMed ID: 28708279
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life three years after diagnosis of head and neck cancer--a longitudinal study.
Hammerlid E; Silander E; Hörnestam L; Sullivan M
Head Neck; 2001 Feb; 23(2):113-25. PubMed ID: 11303628
[TBL] [Abstract][Full Text] [Related]
15. [Head and neck cancer: validation of the QLQ-H&N35 quality of life questionnaire].
Carcamo M; Campo V; Behrmann D; Celedón C; Alvear Á; Vásquez P; Araya C
Rev Med Chil; 2018 May; 146(5):578-584. PubMed ID: 30148921
[TBL] [Abstract][Full Text] [Related]
16. Translation and validation of EORTC QLQ-H&N 35 into Moroccan Arabic for ENT head and neck cancer patients in Morocco.
Ouattassi N; Benmansour N; ElFakir S; Nejjari C; Alami MN
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2727-34. PubMed ID: 26506999
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35.
Bjordal K; Hammerlid E; Ahlner-Elmqvist M; de Graeff A; Boysen M; Evensen JF; Biörklund A; de Leeuw JR; Fayers PM; Jannert M; Westin T; Kaasa S
J Clin Oncol; 1999 Mar; 17(3):1008-19. PubMed ID: 10071296
[TBL] [Abstract][Full Text] [Related]
18. A preliminary study on the relationships between global health/quality of life and specific head and neck cancer quality of life domains in Puerto Rico.
Psoter WJ; Aguilar ML; Levy A; Baek LS; Morse DE
J Prosthodont; 2012 Aug; 21(6):460-71. PubMed ID: 22469330
[TBL] [Abstract][Full Text] [Related]
19. Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase III.
Singer S; Araújo C; Arraras JI; Baumann I; Boehm A; Brokstad Herlofson B; Castro Silva J; Chie WC; Fisher S; Guntinas-Lichius O; Hammerlid E; Irarrázaval ME; Jensen Hjermstad M; Jensen K; Kiyota N; Licitra L; Nicolatou-Galitis O; Pinto M; Santos M; Schmalz C; Sherman AC; Tomaszewska IM; Verdonck de Leeuw I; Yarom N; Zotti P; Hofmeister D;
Head Neck; 2015 Sep; 37(9):1358-67. PubMed ID: 24832623
[TBL] [Abstract][Full Text] [Related]
20. A cross sectional quality of life study of 116 recurrence free head and neck cancer patients. The first use of EORTC H&N35 in Danish.
Jensen K; Jensen AB; Grau C
Acta Oncol; 2006; 45(1):28-37. PubMed ID: 16464793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
